カテゴリ： Market Monitor Global, 世界, 医療/バイオ

塩酸エピネフリン注射のグローバル市場展望 2023年-2029年：0.5mg、01mg

■ 英語タイトル：Epinephrine Hydrochlaride Injection Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5544）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5544
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[塩酸エピネフリン注射のグローバル市場展望 2023年-2029年：0.5mg、01mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の塩酸エピネフリン注射市場規模と予測を収録しています。・世界の塩酸エピネフリン注射市場：売上、2018年-2023年、2024年-2029年
・世界の塩酸エピネフリン注射市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の塩酸エピネフリン注射市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.5mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

塩酸エピネフリン注射のグローバル主要企業は、Shanghai Harvest Pharmaceutical、 Grand Pharmaceutical Group、 TianJin KingYork Group、 Beijing Yongkang Pharmaceutical、 Livealth Biopharma、 Teligent、 Hameln Pharma、 Nephron Pharmaceuticals Corporation、 AdvaCare Pharma、 Adamis Pharmaceuticals Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、塩酸エピネフリン注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の塩酸エピネフリン注射市場：タイプ別、2018年-2023年、2024年-2029年
世界の塩酸エピネフリン注射市場：タイプ別市場シェア、2022年
・0.5mg、01mg

世界の塩酸エピネフリン注射市場：用途別、2018年-2023年、2024年-2029年
世界の塩酸エピネフリン注射市場：用途別市場シェア、2022年
・6歳以下患者、6歳～12歳患者、12歳以上患者

世界の塩酸エピネフリン注射市場：地域・国別、2018年-2023年、2024年-2029年
世界の塩酸エピネフリン注射市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における塩酸エピネフリン注射のグローバル売上、2018年-2023年
・主要企業における塩酸エピネフリン注射のグローバル売上シェア、2022年
・主要企業における塩酸エピネフリン注射のグローバル販売量、2018年-2023年
・主要企業における塩酸エピネフリン注射のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Shanghai Harvest Pharmaceutical、 Grand Pharmaceutical Group、 TianJin KingYork Group、 Beijing Yongkang Pharmaceutical、 Livealth Biopharma、 Teligent、 Hameln Pharma、 Nephron Pharmaceuticals Corporation、 AdvaCare Pharma、 Adamis Pharmaceuticals Corporation

*************************************************************

・調査・分析レポートの概要
塩酸エピネフリン注射市場の定義
市場セグメント
世界の塩酸エピネフリン注射市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の塩酸エピネフリン注射市場規模
世界の塩酸エピネフリン注射市場規模：2022年 VS 2029年
世界の塩酸エピネフリン注射市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの塩酸エピネフリン注射の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の塩酸エピネフリン注射製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：0.5mg、01mg
塩酸エピネフリン注射のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：6歳以下患者、6歳～12歳患者、12歳以上患者
塩酸エピネフリン注射の用途別グローバル売上・予測

・地域別市場分析
地域別塩酸エピネフリン注射市場規模 2022年と2029年
地域別塩酸エピネフリン注射売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Shanghai Harvest Pharmaceutical、 Grand Pharmaceutical Group、 TianJin KingYork Group、 Beijing Yongkang Pharmaceutical、 Livealth Biopharma、 Teligent、 Hameln Pharma、 Nephron Pharmaceuticals Corporation、 AdvaCare Pharma、 Adamis Pharmaceuticals Corporation
...

This report aims to provide a comprehensive presentation of the global market for Epinephrine Hydrochlaride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epinephrine Hydrochlaride Injection. This report contains market size and forecasts of Epinephrine Hydrochlaride Injection in global, including the following market information:
Global Epinephrine Hydrochlaride Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Epinephrine Hydrochlaride Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Epinephrine Hydrochlaride Injection companies in 2022 (%)
The global Epinephrine Hydrochlaride Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.5mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Epinephrine Hydrochlaride Injection include Shanghai Harvest Pharmaceutical, Grand Pharmaceutical Group, TianJin KingYork Group, Beijing Yongkang Pharmaceutical, Livealth Biopharma, Teligent, Hameln Pharma, Nephron Pharmaceuticals Corporation and AdvaCare Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epinephrine Hydrochlaride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epinephrine Hydrochlaride Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epinephrine Hydrochlaride Injection Market Segment Percentages, by Type, 2022 (%)
0.5mg
01 mg
Global Epinephrine Hydrochlaride Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epinephrine Hydrochlaride Injection Market Segment Percentages, by Application, 2022 (%)
Under 6 Years Patients
6 to 12 Years Patients
Over 12 Years Patients
Global Epinephrine Hydrochlaride Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epinephrine Hydrochlaride Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epinephrine Hydrochlaride Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Epinephrine Hydrochlaride Injection revenues share in global market, 2022 (%)
Key companies Epinephrine Hydrochlaride Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Epinephrine Hydrochlaride Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Harvest Pharmaceutical
Grand Pharmaceutical Group
TianJin KingYork Group
Beijing Yongkang Pharmaceutical
Livealth Biopharma
Teligent
Hameln Pharma
Nephron Pharmaceuticals Corporation
AdvaCare Pharma
Adamis Pharmaceuticals Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Epinephrine Hydrochlaride Injection, market overview.
Chapter 2: Global Epinephrine Hydrochlaride Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Epinephrine Hydrochlaride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epinephrine Hydrochlaride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Epinephrine Hydrochlaride Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Epinephrine Hydrochlaride Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epinephrine Hydrochlaride Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epinephrine Hydrochlaride Injection Overall Market Size
2.1 Global Epinephrine Hydrochlaride Injection Market Size: 2022 VS 2029
2.2 Global Epinephrine Hydrochlaride Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Epinephrine Hydrochlaride Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Epinephrine Hydrochlaride Injection Players in Global Market
3.2 Top Global Epinephrine Hydrochlaride Injection Companies Ranked by Revenue
3.3 Global Epinephrine Hydrochlaride Injection Revenue by Companies
3.4 Global Epinephrine Hydrochlaride Injection Sales by Companies
3.5 Global Epinephrine Hydrochlaride Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Epinephrine Hydrochlaride Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Epinephrine Hydrochlaride Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epinephrine Hydrochlaride Injection Players in Global Market
3.8.1 List of Global Tier 1 Epinephrine Hydrochlaride Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Epinephrine Hydrochlaride Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Epinephrine Hydrochlaride Injection Market Size Markets, 2022 & 2029
4.1.2 0.5mg
4.1.3 01 mg
4.2 By Type – Global Epinephrine Hydrochlaride Injection Revenue & Forecasts
4.2.1 By Type – Global Epinephrine Hydrochlaride Injection Revenue, 2018-2023
4.2.2 By Type – Global Epinephrine Hydrochlaride Injection Revenue, 2024-2029
4.2.3 By Type – Global Epinephrine Hydrochlaride Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Epinephrine Hydrochlaride Injection Sales & Forecasts
4.3.1 By Type – Global Epinephrine Hydrochlaride Injection Sales, 2018-2023
4.3.2 By Type – Global Epinephrine Hydrochlaride Injection Sales, 2024-2029
4.3.3 By Type – Global Epinephrine Hydrochlaride Injection Sales Market Share, 2018-2029
4.4 By Type – Global Epinephrine Hydrochlaride Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Epinephrine Hydrochlaride Injection Market Size, 2022 & 2029
5.1.2 Under 6 Years Patients
5.1.3 6 to 12 Years Patients
5.1.4 Over 12 Years Patients
5.2 By Application – Global Epinephrine Hydrochlaride Injection Revenue & Forecasts
5.2.1 By Application – Global Epinephrine Hydrochlaride Injection Revenue, 2018-2023
5.2.2 By Application – Global Epinephrine Hydrochlaride Injection Revenue, 2024-2029
5.2.3 By Application – Global Epinephrine Hydrochlaride Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Epinephrine Hydrochlaride Injection Sales & Forecasts
5.3.1 By Application – Global Epinephrine Hydrochlaride Injection Sales, 2018-2023
5.3.2 By Application – Global Epinephrine Hydrochlaride Injection Sales, 2024-2029
5.3.3 By Application – Global Epinephrine Hydrochlaride Injection Sales Market Share, 2018-2029
5.4 By Application – Global Epinephrine Hydrochlaride Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Epinephrine Hydrochlaride Injection Market Size, 2022 & 2029
6.2 By Region – Global Epinephrine Hydrochlaride Injection Revenue & Forecasts
6.2.1 By Region – Global Epinephrine Hydrochlaride Injection Revenue, 2018-2023
6.2.2 By Region – Global Epinephrine Hydrochlaride Injection Revenue, 2024-2029
6.2.3 By Region – Global Epinephrine Hydrochlaride Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Epinephrine Hydrochlaride Injection Sales & Forecasts
6.3.1 By Region – Global Epinephrine Hydrochlaride Injection Sales, 2018-2023
6.3.2 By Region – Global Epinephrine Hydrochlaride Injection Sales, 2024-2029
6.3.3 By Region – Global Epinephrine Hydrochlaride Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Epinephrine Hydrochlaride Injection Revenue, 2018-2029
6.4.2 By Country – North America Epinephrine Hydrochlaride Injection Sales, 2018-2029
6.4.3 US Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.4.4 Canada Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.4.5 Mexico Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Epinephrine Hydrochlaride Injection Revenue, 2018-2029
6.5.2 By Country – Europe Epinephrine Hydrochlaride Injection Sales, 2018-2029
6.5.3 Germany Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.4 France Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.5 U.K. Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.6 Italy Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.7 Russia Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.8 Nordic Countries Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.5.9 Benelux Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Epinephrine Hydrochlaride Injection Revenue, 2018-2029
6.6.2 By Region – Asia Epinephrine Hydrochlaride Injection Sales, 2018-2029
6.6.3 China Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.6.4 Japan Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.6.5 South Korea Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.6.6 Southeast Asia Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.6.7 India Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Epinephrine Hydrochlaride Injection Revenue, 2018-2029
6.7.2 By Country – South America Epinephrine Hydrochlaride Injection Sales, 2018-2029
6.7.3 Brazil Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.7.4 Argentina Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Epinephrine Hydrochlaride Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Epinephrine Hydrochlaride Injection Sales, 2018-2029
6.8.3 Turkey Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.8.4 Israel Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Epinephrine Hydrochlaride Injection Market Size, 2018-2029
6.8.6 UAE Epinephrine Hydrochlaride Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shanghai Harvest Pharmaceutical
7.1.1 Shanghai Harvest Pharmaceutical Company Summary
7.1.2 Shanghai Harvest Pharmaceutical Business Overview
7.1.3 Shanghai Harvest Pharmaceutical Epinephrine Hydrochlaride Injection Major Product Offerings
7.1.4 Shanghai Harvest Pharmaceutical Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.1.5 Shanghai Harvest Pharmaceutical Key News & Latest Developments
7.2 Grand Pharmaceutical Group
7.2.1 Grand Pharmaceutical Group Company Summary
7.2.2 Grand Pharmaceutical Group Business Overview
7.2.3 Grand Pharmaceutical Group Epinephrine Hydrochlaride Injection Major Product Offerings
7.2.4 Grand Pharmaceutical Group Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.2.5 Grand Pharmaceutical Group Key News & Latest Developments
7.3 TianJin KingYork Group
7.3.1 TianJin KingYork Group Company Summary
7.3.2 TianJin KingYork Group Business Overview
7.3.3 TianJin KingYork Group Epinephrine Hydrochlaride Injection Major Product Offerings
7.3.4 TianJin KingYork Group Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.3.5 TianJin KingYork Group Key News & Latest Developments
7.4 Beijing Yongkang Pharmaceutical
7.4.1 Beijing Yongkang Pharmaceutical Company Summary
7.4.2 Beijing Yongkang Pharmaceutical Business Overview
7.4.3 Beijing Yongkang Pharmaceutical Epinephrine Hydrochlaride Injection Major Product Offerings
7.4.4 Beijing Yongkang Pharmaceutical Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.4.5 Beijing Yongkang Pharmaceutical Key News & Latest Developments
7.5 Livealth Biopharma
7.5.1 Livealth Biopharma Company Summary
7.5.2 Livealth Biopharma Business Overview
7.5.3 Livealth Biopharma Epinephrine Hydrochlaride Injection Major Product Offerings
7.5.4 Livealth Biopharma Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.5.5 Livealth Biopharma Key News & Latest Developments
7.6 Teligent
7.6.1 Teligent Company Summary
7.6.2 Teligent Business Overview
7.6.3 Teligent Epinephrine Hydrochlaride Injection Major Product Offerings
7.6.4 Teligent Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.6.5 Teligent Key News & Latest Developments
7.7 Hameln Pharma
7.7.1 Hameln Pharma Company Summary
7.7.2 Hameln Pharma Business Overview
7.7.3 Hameln Pharma Epinephrine Hydrochlaride Injection Major Product Offerings
7.7.4 Hameln Pharma Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.7.5 Hameln Pharma Key News & Latest Developments
7.8 Nephron Pharmaceuticals Corporation
7.8.1 Nephron Pharmaceuticals Corporation Company Summary
7.8.2 Nephron Pharmaceuticals Corporation Business Overview
7.8.3 Nephron Pharmaceuticals Corporation Epinephrine Hydrochlaride Injection Major Product Offerings
7.8.4 Nephron Pharmaceuticals Corporation Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.8.5 Nephron Pharmaceuticals Corporation Key News & Latest Developments
7.9 AdvaCare Pharma
7.9.1 AdvaCare Pharma Company Summary
7.9.2 AdvaCare Pharma Business Overview
7.9.3 AdvaCare Pharma Epinephrine Hydrochlaride Injection Major Product Offerings
7.9.4 AdvaCare Pharma Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.9.5 AdvaCare Pharma Key News & Latest Developments
7.10 Adamis Pharmaceuticals Corporation
7.10.1 Adamis Pharmaceuticals Corporation Company Summary
7.10.2 Adamis Pharmaceuticals Corporation Business Overview
7.10.3 Adamis Pharmaceuticals Corporation Epinephrine Hydrochlaride Injection Major Product Offerings
7.10.4 Adamis Pharmaceuticals Corporation Epinephrine Hydrochlaride Injection Sales and Revenue in Global (2018-2023)
7.10.5 Adamis Pharmaceuticals Corporation Key News & Latest Developments
8 Global Epinephrine Hydrochlaride Injection Production Capacity, Analysis
8.1 Global Epinephrine Hydrochlaride Injection Production Capacity, 2018-2029
8.2 Epinephrine Hydrochlaride Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Epinephrine Hydrochlaride Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Epinephrine Hydrochlaride Injection Supply Chain Analysis
10.1 Epinephrine Hydrochlaride Injection Industry Value Chain
10.2 Epinephrine Hydrochlaride Injection Upstream Market
10.3 Epinephrine Hydrochlaride Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Epinephrine Hydrochlaride Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 塩酸エピネフリン注射のグローバル市場展望 2023年-2029年：0.5mg、01mg
  • 高精度分析天びんのグローバル市場展望 2023年-2029年：可読性 0.01mg、可読性 0.02mg、可読性 0.05mg、その他
  • アレルギー治療用エピネフリンのグローバル市場展望 2023年-2029年：エピネフリン自動注射器、塩酸エピネフリン注射器、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5544 )"塩酸エピネフリン注射のグローバル市場展望 2023年-2029年：0.5mg、01mg" (英文：Epinephrine Hydrochlaride Injection Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。